Biomarkers for predicting type 2 diabetes development—Can metabolomics improve on existing biomarkers?
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Biomarkers for predicting type 2 diabetes development—Can metabolomics improve on existing biomarkers?
Authors
Keywords
Metabolomics, Type 2 diabetes, Adiponectin, Glucose metabolism, Forecasting, Metabolites, Biomarkers, Diabetes mellitus
Journal
PLoS One
Volume 12, Issue 7, Pages e0177738
Publisher
Public Library of Science (PLoS)
Online
2017-07-11
DOI
10.1371/journal.pone.0177738
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Metabolite targeting: development of a comprehensive targeted metabolomics platform for the assessment of diabetes and its complications
- (2016) Ernst Meiss et al. Metabolomics
- Dimethylglycine Deficiency and the Development of Diabetes
- (2015) Martin Magnusson et al. DIABETES
- Metabolomic Profile Associated With Insulin Resistance and Conversion to Diabetes in the Insulin Resistance Atherosclerosis Study
- (2015) Nicholette D. Palmer et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- A Simultaneous Metabolic Profiling and Quantitative Multimetabolite Metabolomic Method for Human Plasma Using Gas-Chromatography Tandem Mass Spectrometry
- (2015) Otto I. Savolainen et al. JOURNAL OF PROTEOME RESEARCH
- Forecasting individual breast cancer risk using plasma metabolomics and biocontours
- (2015) Rasmus Bro et al. Metabolomics
- glmulti: AnRPackage for Easy Automated Model Selection with (Generalized) Linear Models
- (2015) Vincent Calcagno et al. Journal of Statistical Software
- Biomarkers for Type 2 Diabetes and Impaired Fasting Glucose Using a Nontargeted Metabolomics Approach
- (2013) C. Menni et al. DIABETES
- Mendelian Randomization Studies Do Not Support a Causal Role for Reduced Circulating Adiponectin Levels in Insulin Resistance and Type 2 Diabetes
- (2013) H. Yaghootkar et al. DIABETES
- The potential of novel biomarkers to improve risk prediction of type 2 diabetes
- (2013) Christian Herder et al. DIABETOLOGIA
- 2-Aminoadipic acid is a biomarker for diabetes risk
- (2013) Thomas J. Wang et al. JOURNAL OF CLINICAL INVESTIGATION
- Towards metabolic biomarkers of insulin resistance and type 2 diabetes: progress from the metabolome
- (2013) Lee D Roberts et al. Lancet Diabetes & Endocrinology
- Identification of Serum Metabolites Associated With Risk of Type 2 Diabetes Using a Targeted Metabolomic Approach
- (2012) A. Floegel et al. DIABETES
- Early Metabolic Markers of the Development of Dysglycemia and Type 2 Diabetes and Their Physiological Significance
- (2012) E. Ferrannini et al. DIABETES
- Novel biomarkers for pre-diabetes identified by metabolomics
- (2012) Rui Wang-Sattler et al. Molecular Systems Biology
- Metabolite profiles and the risk of developing diabetes
- (2011) Thomas J Wang et al. NATURE MEDICINE
- Adiponectin in relation to insulin sensitivity and insulin secretion in the development of type 2 diabetes: a prospective study in 64-year-old women
- (2010) B. Fagerberg et al. JOURNAL OF INTERNAL MEDICINE
- Plasma Metabolomic Profiles Reflective of Glucose Homeostasis in Non-Diabetic and Type 2 Diabetic Obese African-American Women
- (2010) Oliver Fiehn et al. PLoS One
- A Branched-Chain Amino Acid-Related Metabolic Signature that Differentiates Obese and Lean Humans and Contributes to Insulin Resistance
- (2009) Christopher B. Newgard et al. Cell Metabolism
- Adiponectin Levels and Risk of Type 2 Diabetes
- (2009) Shanshan Li et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation